QMS Medical Allied Services (NSE:QMSMEDI) Marketable Securities: ₹55 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:QMSMEDI QMS Medical Allied Services Ltd NSE:QMSMEDI
69 GF Score
Price ₹148.39
GF Value ₹121.42
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is QMS Medical Allied Services Marketable Securities?

QMS Medical Allied Services NSE:QMSMEDI +5.00% 69 Marketable Securities is ₹55 Mil as of Mar. 2026. GuruFocus rates NSE:QMSMEDI with a GF Score™ of 69/100 and a GF Value™ of ₹121.42 (Modestly Overvalued). The stock has 6 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. QMS Medical Allied Services's Marketable Securities for the quarter that ended in Mar. 2026 was ₹55 Mil.

QMS Medical Allied Services's annual Marketable Securities increased from Mar. 2024 (₹21 Mil) to Mar. 2025 (₹32 Mil) and increased from Mar. 2025 (₹32 Mil) to Mar. 2026 (₹55 Mil).

QMS Medical Allied Services  (NSE:QMSMEDI) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

QMS Medical Allied Services Marketable Securities Related Terms

QMS Medical Allied Services Marketable Securities Historical Data

* Premium members only.

The historical data trend for QMS Medical Allied Services's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

QMS Medical Allied Services Marketable Securities Chart

QMS Medical Allied Services Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Marketable Securities
Get a 7-Day Free Trial 0.00 0.00 21.06 32.32 54.65

QMS Medical Allied Services Quarterly Data
Mar20 Mar21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 32.32 0.00 11.72 0.00 54.65
NSE:QMSMEDI
69GF Score
QMS Medical Allied Services Ltd NSE:QMSMEDI
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

QMS Medical Allied Services Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of ₹55 Mil mean?
QMS Medical Allied Services (NSE:QMSMEDI) has a Marketable Securities of ₹55 Mil as of Mar. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on QMS Medical Allied Services and its competitors.
Is QMS Medical Allied Services' Marketable Securities too high?
QMS Medical Allied Services' current Marketable Securities is ₹55 Mil. Overall, QMS Medical Allied Services has a GF Score™ of 69/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does QMS Medical Allied Services' Marketable Securities compare to ISRG and BDX?
QMS Medical Allied Services' Marketable Securities of ₹55 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Medical Devices & Instruments company?
A good Marketable Securities depends on the Medical Devices & Instruments industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on QMS Medical Allied Services and its competitors. QMS Medical Allied Services's current Marketable Securities is ₹55 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is QMS Medical Allied Services stock overvalued right now?
Based on GuruFocus' analysis, QMS Medical Allied Services (NSE:QMSMEDI) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹121.42, compared to a current price of ₹148.39 — trading 22.2% above its estimated fair value. The current Marketable Securities is ₹55 Mil. QMS Medical Allied Services' overall GF Score™ is 69/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For QMS Medical Allied Services (NSE:QMSMEDI), the current Marketable Securities is ₹55 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is QMS Medical Allied Services (NSE:QMSMEDI) Overvalued in 2026?

Based on GuruFocus' analysis, QMS Medical Allied Services stock appears to be overvalued. The current stock price of ₹148.39 is trading 22.2% above its estimated GF Value™ of ₹121.42. GuruFocus considers QMS Medical Allied Services to be Modestly Overvalued.

Key valuation signals for NSE:QMSMEDI:

  • Marketable Securities: ₹55 Mil
  • GF Value™: ₹121.42 vs. price of ₹148.39 (22.2% above fair value)
  • GF Score™: 69/100 with 6 warning signs

No single metric tells the full story. See the NSE:QMSMEDI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

QMS Medical Allied Services Business Description

Address Prabhat Colony, Road No. 3, 1A-B/2A-B, Navkala Bharti Building, Plot No. 16, Near Santacruz Bus Depot, Santacruz (East), Mumbai, MH, IND, 400055
QMS Medical Allied Services Ltd is engaged in the marketing and distribution of a wide range of medical products as well as medical education services. The company's products are sold under brand name "QDevices" and also manage the distribution for other brands such as 3M, Heine, Rossmax and others. It offers medical products such as Blood Pressure Monitors, Glucose Monitoring Kits and strips, Dental Products, Personal protection kits eg-PPE kits, Infection prevention, Stethoscope and Oxygen Concentrator.
69GF Score

Get the complete analysis for NSE:QMSMEDI

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹148.39
Price
₹121.42
GF Value